354 related articles for article (PubMed ID: 32462419)
1. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
2. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
Wu X; Tanaka H
Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
[TBL] [Abstract][Full Text] [Related]
3. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.
Vizza E; Corrado G; De Angeli M; Carosi M; Mancini E; Baiocco E; Chiofalo B; Patrizi L; Zampa A; Piaggio G; Cicchillitti L
J Exp Clin Cancer Res; 2018 Jan; 37(1):16. PubMed ID: 29382392
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
Yang X; Zhang K; Zhang C; Peng R; Sun C
BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
[TBL] [Abstract][Full Text] [Related]
5. Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.
Ritter M; Paradiso V; Widmer P; Garofoli A; Quagliata L; Eppenberger-Castori S; Soysal SD; Muenst S; Ng CKY; Piscuoglio S; Weber W; Weber WP
Clin Breast Cancer; 2020 Oct; 20(5):413-421.e1. PubMed ID: 32650988
[TBL] [Abstract][Full Text] [Related]
6. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
7. A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Bortul M; Giudici F; Tierno D; Generali D; Scomersi S; Grassi G; Bottin C; Cappelletti MR; Zanconati F; Scaggiante B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239866
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.
Ashley CW; Selenica P; Patel J; Wu M; Nincevic J; Lakhman Y; Zhou Q; Shah RH; Berger MF; Da Cruz Paula A; Brown DN; Marra A; Iasonos A; Momeni-Boroujeni A; Alektiar KM; Long Roche K; Zivanovic O; Mueller JJ; Zamarin D; Broach VA; Sonoda Y; Leitao MM; Friedman CF; Jewell E; Reis-Filho JS; Ellenson LH; Aghajanian C; Abu-Rustum NR; Cadoo K; Weigelt B
Clin Cancer Res; 2023 Jan; 29(2):410-421. PubMed ID: 36007103
[TBL] [Abstract][Full Text] [Related]
12. Telomere length varies by DNA extraction method: implications for epidemiologic research.
Cunningham JM; Johnson RA; Litzelman K; Skinner HG; Seo S; Engelman CD; Vanderboom RJ; Kimmel GW; Gangnon RE; Riegert-Johnson DL; Baron JA; Potter JD; Haile R; Buchanan DD; Jenkins MA; Rider DN; Thibodeau SN; Petersen GM; Boardman LA
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2047-54. PubMed ID: 24019396
[TBL] [Abstract][Full Text] [Related]
13. Higher peripheral blood mitochondrial DNA copy number and relative telomere length in under 48 years Indonesian breast cancer patients.
Limardi PC; Panigoro SS; Siregar NC; Sutandyo N; Witjaksono F; Priliani L; Oktavianthi S; Malik SG
BMC Res Notes; 2024 Apr; 17(1):120. PubMed ID: 38679744
[TBL] [Abstract][Full Text] [Related]
14. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer.
Ronchetti L; Terrenato I; Ferretti M; Corrado G; Goeman F; Donzelli S; Mandoj C; Merola R; Zampa A; Carosi M; Blandino G; Conti L; Lobascio AM; Iacobelli M; Vizza E; Piaggio G; Gurtner A
J Exp Clin Cancer Res; 2022 Apr; 41(1):151. PubMed ID: 35449078
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
[TBL] [Abstract][Full Text] [Related]
16. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
[TBL] [Abstract][Full Text] [Related]
17. Relative telomere length and oxidative stress in musculoskeletal tumors.
Tanpaisankit M; Hongsaprabhas C; Chareonlap C; Honsawek S
Mol Biol Rep; 2019 Aug; 46(4):4009-4016. PubMed ID: 31069615
[TBL] [Abstract][Full Text] [Related]
18. Relative telomere length and prostate cancer mortality.
Renner W; Krenn-Pilko S; Gruber HJ; Herrmann M; Langsenlehner T
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):579-583. PubMed ID: 30082901
[TBL] [Abstract][Full Text] [Related]
19. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
20. Association between leukocyte telomere length and glioma risk: a case-control study.
Wang S; Chen Y; Qu F; He S; Huang X; Jiang H; Jin T; Wan S; Xing J
Neuro Oncol; 2014 Apr; 16(4):505-12. PubMed ID: 24366909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]